OmniScience and INmune Bio announced a pioneering partnership to revolutionize operations for INmune Bio’s global Phase 2 Alzheimer’s disease (AD) clinical trial (the “AD02 trial”) using...
Slingshot Biosciences announced the addition of Nimisha Srivastava, Ph.D., as Chief Operations Officer. Dr. Srivastava brings more than 20 years of experience in nanofluidics,...
Cellino Biotech, Inc., a biotechnology company advancing autonomous, closed biomanufacturing for personalized regenerative medicines, announced the appointment of Chris Gemmiti, Ph.D., as Senior Vice...
Nature’s Toolbox, Inc. (NTx), a life science company developing domestically-sourced biomanufacturing solutions for the delivery of personalized therapeutics and biologics, announced it secured $15...
Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, announced that it has entered into an agreement...
